London — DeepMind, the UK-based artificial intelligence company owned by Alphabet, has said it can predict the structure of proteins, a breakthrough that could dramatically speed up the discovery of new drugs.
Scientists have spent decades trying to work out how proteins, which begin as strings of chemical compounds, fold into three-dimensional shapes, which then define their behaviour...A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: